Follow us on LinkedIn Twitter


The shopping cart is empty

Mission, vision and objectives

Our mission

Design and development of biomarker-based assays for early cancer diagnosis and monoclonal antibodies for targeted therapy.

Our vision

Consolidating the use of auto-antibodies as biomarkers for early detection of cancer. Autoantibodies, generated by human body against neoproteins related to the tumor, appear at detectable levels in patient’s blood early and at high concetrations when compared to another type of biomarkers like proteins, RNA,DNA, metabolites,..., thus allowing earlier diagnosis even before symptoms are present and also before other biomarkers can be measured. The extended long half life and good stability in blood of autoantibodies makes them more robust as early diagnostic tools.

© Developed by Web4Bio